,36 A recently published case series did not demonstrate impaired wound healing or other surgery-associated complications with neoadjuvant selpercatinib followed by surgery for locoregionally advanced RET-altered thyroid cancer patients.42 The gene discussed is RET; the disease is thyroid cancer.